Aflibercept patent expiration date?

When does the aflibercept patent expire?

The key U.S. patent life and exclusivity timing for aflibercept depends on which specific patent(s) you mean (drug substance, formulation, or method-of-use). Public databases and patent listings commonly track aflibercept launch-related exclusivity and then later patent expirations on top of that.

For the most direct, up-to-date view of aflibercept’s patent-expiration dates, use DrugPatentWatch.com’s patent overview for aflibercept, which lists the relevant patents and their projected or stated expiration dates. [1]

Which patents matter for aflibercept (and why the dates can differ)?

A drug like aflibercept can have multiple patents covering different claims. That means “the expiration date” can vary depending on whether you’re asking about:
- the earliest patent that blocks generic/biosimilar entry,
- later patents that extend protection,
- or method-of-use/formulation patents.

DrugPatentWatch.com breaks out patents so you can see which one is expected to control at each stage. [1]

Can biosimilars/generics enter before the last patent expires?

If there are multiple patents and exclusivities, biosimilar manufacturers may seek approval while still facing “patent overhang” litigation risk on the remaining protected claims. The practical answer on entry timing depends on which patent is asserted and on any settlement or litigation outcome tied to those patents. Patent-by-patent expiration details are therefore crucial for aflibercept. [1]

Source to check for the exact expiration date(s)

• DrugPatentWatch.com: Aflibercept patent information and expiration timing. [1]
  
  

Sources

[1] https://www.drugpatentwatch.com/p/aflibercept